The present invention relates to compounds of Formula I, a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesoid X receptors (FXR).
本发明涉及公式I的化合物、立体异构体、对映体、药用可接受的盐或其
氨基酸结合物;其中变量如本文所定义;以及它们的药用组合物,用作法尼索尔X受体(FXR)活性调节剂。